Spark Therapeutics (ONCE) Misses Q3 EPS by 6c

November 3, 2016 8:44 AM EDT
Get Alerts ONCE Hot Sheet
Trade ONCE Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Spark Therapeutics (NASDAQ: ONCE) reported Q3 EPS of ($1.07), $0.06 worse than the analyst estimate of ($1.01). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $1.26 million.

For earnings history and earnings-related data on Spark Therapeutics (ONCE) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment